Reports
Assisted Reproductive Technology Market Growth, Industry Analysis, 2026-2034
REPORT DETAILS
REPORT DETAILS
ABOUT THIS REPORT
Market Statistics
Key Takeaways
- North America dominated with approximately
.49.58% share in 2025 driven by a well-established healthcare system and strong adoption of advanced fertility treatments. - Asia Pacific is expected to witness the growth rate of CAGR 6.5% during the forecast period driven by a large population and rising infertility rates.
- Based on procedure, the in-vitro fertilization dominated with nearly 33.29% market share in 2025 due to its high success rates and wide applicability across different infertility conditions
- Consumables segment is expected to witness significant growth rate of CAGR 5.9% during the forecast period due to their essential and repetitive use in every fertility procedure
- Fertility clinics & other facilities acquired largest share of 46.75% in 2025 as they are the primary centers for diagnosis, treatment, and patient management
What is Assisted Reproductive Technology Market Size?
The global assisted reproductive technology market size was valued at USD 30.88 billion in 2025, growing at a CAGR of 6.2% from 2026–2034. Key factors driving the growth is rising infertility rates, rise in fertility preservation demand, and technological advancement.
Industry Dynamics
- The increase in the infertility rates globally is driving the market growth.
- Rise in the fertility preservation demand is fueling the growth.
- Technological advancement is boosting the growth.
- High costs limit the growth of the market in developing regions.
AI Impact on Assisted Reproductive Technology Market
- AI helps in effective decision-making in terms of treatment plan by analyzing patient data and making decisions for fertility.
- AI helps in selecting the right embryo that can increase the probability of success.
- AI contributes to the efficiency of workflow by minimizing manual procedures.
- It contributes to patient care by facilitating quick updates and offering virtual guidance.
What is Assisted Reproductive Technology (ART) and How It Works?
Assisted reproductive technology (ART) is a collection of medical procedures for the treatment of infertility. This entails handling of eggs, sperm, or embryos to assist a woman in conceiving in situations where natural conception fails.
The procedure begins with ovarian stimulation using drugs that cause more than one egg to form. This is followed by fertilization of the retrieved eggs with sperm in laboratory conditions, either naturally or through intra-cytoplasmic sperm injection. Embryo development is monitored until a good embryo can be selected and transferred into the uterus. There is also an option of freezing embryos for later use. This procedure makes use of highly advanced equipment to increase its effectiveness and safety.
ART Procedure Types
- In-Vitro Fertilization (IVF): Fertilization of the egg by the sperm occurs in a laboratory, followed by transfer of the embryo into the uterus.
- Intracytoplasmic Sperm Injection (ICSI): Intra-cytoplasmic injection of one sperm into an egg is done to facilitate fertilization.
- Donation of Eggs and Sperms: When required, donor eggs or sperms are used.
- Surrogacy: Embryo transfer is carried out into another individual who acts as a surrogate mother.
- Cryopreservation: Storage of eggs, sperms, or embryos for future use.
What Is Included in the Assisted Reproductive Technology Market?
The market consists several procedures in the assisted reproductive technology such as IVF, ICSI, frozen embryo transfer, donor cycles, and artificial insemination. The demand of procedure in different settings such as fertility clinics & other facilities, hospitals, and others facilities is also being studied in the market. Moreover, different patient demographics are also included in the market to identify distinct infertility factors, such as male factor infertility and female reproductive health conditions. This supports the development of targeted therapies, diagnostics, and services tailored to gender-specific needs and outcomes.
To Understand More About this Research: Download Sample Report
Drivers & Opportunities
What are Factors Driving Industry Growth?
Rising Infertility Rates Globally: The prevalence of infertility worldwide is increasing. Factors such as delayed parenthood, rising stress levels, unhealthy lifestyles, obesity, and exposure to environmental pollutants have significantly impacted reproductive health. Additionally, conditions such as endometriosis and polycystic ovary syndrome are becoming more common which is further contributing to fertility challenges. As a result, a growing number of individuals are seeking medical assistance for conception. This rising demand is reflected in the increasing number of fertility treatments, including IVF and other procedures. For instance, according to the American Society for Reproductive Medicine, U.S. IVF cycles at 371 reporting SART member clinics increased from 389,993 in 2022 to 432,641 in 2023, while the number of babies born from IVF rose from 91,771 to 95,860. This highlights a strong need for ART services globally, thereby driving the industry growth.
Technological Advancements in ART: Advancements in assisted reproductive technology are improving the appeal, with increasing emphasis on the commercial value of innovation. While developments such as ICSI, preimplantation genetic testing (PGT), embryo monitoring, and vitrification continue to improve clinical outcomes and enable personalized treatments, the growing adoption of advanced workflow technologies is becoming a major differentiator. Fertility clinics are increasingly using laboratory automation, improved culture media, time-lapse embryo monitoring, and AI-assisted embryo selection to improve success rates and patient experience. These technologies improve accuracy and support scalability and protocol standardization across clinic networks, allowing providers to handle higher treatment volumes efficiently and strengthen their competitive positioning in the market.
Expanding Fertility Preservation Demand: The demand for fertility preservation is increasing. More individuals are choosing options such as egg freezing, embryo banking, and sperm preservation due to delayed parenthood, medical treatments such as chemotherapy, or a desire for greater reproductive control. This shift is expanding the scope of ART beyond traditional infertility treatment. As a result, there is increasing demand for related services such as cryopreservation, long-term storage, and advanced laboratory infrastructure. Additionally, the rising awareness and clinical focus on fertility preservation are encouraging more patients to consider these options which is expected to open new opportunities, thereby driving the industry growth.
Reimbursement, Regulation, and Access as Market Variables: Reimbursement policies and regulatory frameworks is shaping the industry. Countries with strong insurance coverage, government support, and clear regulations tend to see higher adoption of fertility treatments and more developed clinic networks. While, high out-of-pocket costs remain a major barrier in many regions, limiting patient access to ART services. Affordability challenges continue to impact treatment decisions, especially in developing regions. As a result, the policy environment significantly influences regional market performance, with supportive reimbursement systems and well-defined regulations helping to drive higher treatment volumes and overall market expansion.
Success Rates, Advantages, and Risks
The success rate varies depending on age, health status, and the method used. Young people have a better success rate, and innovations are boosting results.
Advantages:
- Increases the probability of conception
- Treatment plans can be customized to suit individual needs
- Helps plan fertility in advance
- Reduces the chances of having genetic conditions
Disadvantages:
- Higher chances of multiple pregnancies
- Health problems like ovarian stimulation
- Costly procedures
- Knowledge of these aspects enables people to make an informed choice regarding ART treatment.
Segmental Insights
What are the Segmental Insights by Procedure?
Based on procedure, the in-vitro fertilization dominated with nearly 33.29% market share in 2025 due to its high success rates and wide applicability across different infertility conditions. IVF is commonly recommended for both male and female infertility. This makes it a preferred choice among patients and healthcare providers. Technological advancement such as better embryo selection and culture techniques, have further improved its effectiveness. Additionally, increasing awareness and acceptance of IVF are driving higher procedure volumes globally, thereby driving the segment growth.
Which Segment by Product & Service is Expected to Witness Significant Growth?
Consumables segment is expected to witness growth rate of CAGR 5.9% during the forecast period due to their essential and repetitive use in every fertility procedure. These include culture media, reagents, catheters, and cryopreservation solutions, all of which are required at multiple stages of treatment. Unlike equipment, consumables need to be replenished regularly, ensuring a steady and recurring revenue stream for market players. The demand for high-quality consumables is rising significantly with the increasing number of ART cycles being performed worldwide. Moreover, the advancements in product quality and performance is further driving the segment growth, thereby driving the segment growth.
Why Fertility Clinics & Other Facilities Dominated the End Use Segment?
Fertility clinics & other facilities dominated with 46.75% share in 2025 as they are the primary centers for diagnosis, treatment, and patient management. These clinics are equipped with advanced technologies, skilled professionals, and dedicated laboratories. This enables them to offer comprehensive fertility services. Patients prefer specialized clinics due to higher success rates and personalized care. The increasing number of fertility centers, along with growing investments in healthcare infrastructure, is further driving the demand for ART services in fertility clinics, thereby driving the segment growth.
Why Male Fertility is Expected to Register Significant Growth?
Based on patient type, male fertility is expected to witness growth rate of CAGR 6.2% during the forecast period as awareness and diagnosis of male-related infertility issues continue to increase. Factors such as lifestyle changes, stress, environmental exposure, and health conditions are contributing to declining male fertility rates. As a result, more men are seeking medical evaluation and treatment, leading to higher demand for ART procedures. Technologies such as ICSI have made it easier to address male infertility effectively, further fueling segment growth.
Regional Analysis
What are Regional Statistics of Industry?
North America
North America dominated with approx. 49.58% share in 2025 driven by a well-established healthcare system and strong adoption of advanced fertility treatments. The region benefits from a large number of specialized fertility clinics, high healthcare spending, and widespread awareness about infertility treatments. Additionally, the presence of structured clinical reporting systems and transparent success rate data helps build patient trust and supports higher treatment uptake. Moreover, technological advancements and availability of skilled professionals are further driving the industry growth in region.
Europe
Europe is expected to witness the growth rate of CAGR 6.1% during the forecast period due to its large procedure volumes and well-developed clinical standards. The region has a strong network of fertility clinics and follows established treatment protocols, ensuring consistent quality of care. Regulatory frameworks and ongoing data tracking across countries support better transparency and understanding of treatment outcomes. Europe further shows steady demand for advanced procedures such as IVF, ICSI, and frozen embryo transfer. Moreover, continuous improvements in clinical practices and supportive healthcare systems in several countries of Europe is further driving the demand, thereby fueling the regional growth.
Asia Pacific
Asia Pacific is expected to witness the fastest growth rate of CAGR 6.5% during the forecast period driven by a large population and rising infertility rates. Increasing awareness, improving income levels, and better access to fertility treatments are encouraging more patients to seek ART services. The expansion of private fertility clinics and growing investment in healthcare infrastructure are further supporting the growth. Additionally, the region is becoming a popular destination for fertility tourism due to relatively lower treatment costs. Countries such as India, China, and Japan are playing a major role in driving demand and making Asia Pacific a high-potential growth region.
Regional Policy, Reimbursement, and Medical Tourism Trends
The regional policies emphasize strict regulation and ethical oversight. India's 2021 ART Act mandates clinic registration, age limits (women 21-50, men 21-55), and National/State Boards for supervision, with 2025 amendments improving enforcement. Europe features varied legislation across 43 countries, focusing on embryo limits and registries, per ESHRE surveys. Japan covers ART via insurance for women under 43 since 2022, boosting access in rural areas.
Reimbursement differs sharply: limited in India (some private policies like Star Health after 36 months and the US (state-dependent, post-Dobbs challenges), while Europe offers partial public funding with age/cycle caps, and Japan saw 4% patient growth post-coverage.
Medical tourism thrives in cost-effective hubs like India, Turkey, Greece, Spain, and Iran, drawing 2M annual visitors for IVF amid rising infertility and tech advances like AI. These trends expand access but highlight affordability gaps in high-cost regions.
Key Players & Competitive Analysis
The market is being shaped by several important competitive trends. One key trend is the growing consolidation of fertility clinics, supported by private investments to expand multi-location networks. At the same time, companies are focusing on product innovation, especially in advanced consumables, embryo handling, cryopreservation, and automated lab systems to improve outcomes. The increasing need for clinical standardization across fertility networks to ensure consistent results and better patient experience is another factor. Together, these trends are strengthening both service delivery and product development, helping companies improve efficiency, scale operations, and improve their competitive position in the market
Key Players
- Boston IVF
- CooperSurgical, Inc.
- Esco Micro Pte. Ltd.
- FUJIFILM Irvine Scientific, Inc.
- Genea Biomedx Pty Ltd
- IVFtech a.s.
- Kitazato Corporation
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Vitrolife AB
Industry Developments
- March 2026, Nova IVF Fertility acquired CRAFT Fertility to enter Kerala's market. The strategic acquisition positions the company to launch 10 new centres, enhancing accessible IVF services across the state [Source: Nova Fertility.com]
- June 2025, KKR-backed IVI RMA moved to acquire ART Fertility Clinics for USD 400–450 million, expanding into India and the UAE. The deal added 14 clinics which reflects investor interest in fertility clinic platforms. [Source:
- October 2024, SpOvum Technologies launched an AI-powered ART platform, ARTGPT, to enhance patient engagement with 24/7 multilingual support. The solution improved accessibility, delivered personalized reproductive health information, and strengthened patient-provider communication through secure, data-driven insights across India.[Source:
Assisted Reproductive Technology Market Segmentation
By Procedure Outlook (Revenue, USD Billion, 2021–2034)
- In-Vitro Fertilization (IVF)
- ICSI
- Frozen Embryo Transfer
- Donor Cycles
- Artificial Insemination
By Product & Service Outlook (Revenue, USD Billion, 2021–2034)
- Media
- Consumables
- Instruments
- Cryopreservation Solutions
- Clinical & Laboratory Services
By End Use Outlook (Revenue, USD Billion, 2021–2034)
- Fertility Clinics & Other Facilities
- Hospitals
- Others
By Patient Type Outlook (Revenue, USD Billion, 2021–2034)
- Female Infertility
- Male Infertility
- Combined Infertility
- Elective Fertility Preservation
By Regional Outlook (Revenue, USD Billion, 2021–2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Assisted Reproductive Technology Market Report Scope
| Report Attributes | Details |
| Market Size in 2025 | USD 30.88 Billion |
| Market Size in 2026 | USD 32.75 Billion |
| Revenue Forecast by 2034 | USD 52.85 Billion |
| CAGR | 6.2% from 2026 to 2034 |
| Base Year | 2025 |
| Historical Data | 2021–2024 |
| Forecast Period | 2026–2034 |
| Quantitative Units | Revenue in USD Billion and CAGR from 2026 to 2034 |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Industry Trends |
| Segments Covered |
|
| Regional Scope |
|
| Competitive Landscape |
|
| Report Format |
|
| Customization | Report customization as per your requirements with respect to countries, regions, and segmentation. |
FAQ's
The global market size was valued at USD 30.88 billion in 2025 and is projected to grow to USD 52.85 billion by 2034.
Growth is being supported by rising infertility prevalence, delayed parenthood, broader acceptance of fertility treatment, clinic expansion, fertility preservation demand, and continued advances in IVF, ICSI, genetic testing, and cryopreservation. WHO estimates that approximately one in six people experience infertility in their lifetime.
IVF accounts for the 33.29% share due to its broad use across multiple infertility indications and its established clinical success profile.
Artificial insemination and fertility preservation-related services are among the faster-growing segments with CAGR of 6.4% due to lower-cost treatment pathways, expanding access, and growing elective reproductive planning.
North America currently leads the global assisted reproductive technology market with 49.80% share in 2025, supported by mature fertility infrastructure, strong technology adoption, and established clinical reporting systems.
Asia Pacific is expected to exhibit the highest CAGR of 6.5% due to rising infertility rates, increasing private fertility investment, expanding clinic networks, and growth in medical tourism.
Major challenges include high treatment costs, uneven reimbursement, regulatory variability, access disparities, and the need for continued improvement in affordability and treatment consistency.
Fertility preservation is becoming a major growth area, supported by demand for egg freezing, embryo banking, and sperm preservation among patients delaying parenthood and those seeking treatment before medical interventions that may affect fertility
Fertility Success rates influence patient confidence, clinic selection, and treatment adoption.
Download Sample Report of Assisted Reproductive Technology Market
Please fill out the form to request a customized copy of the research report.
